HealthTree Featured on Outsourcing Pharma News

MC NEWSROOM - July 10, 2020

In an article entitled "Portal matches myeloma patients to clinical care", author Jenni Spinner on Outsourcing Pharma shared how the pl... Read More

July 11 Interactive Webcast: Using Three New Myeloma Therapies (Selinexor, Isatuximab, Darzalex FasPro) with Three Myeloma Experts

Learn about three new therapies being incorporated in myeloma treatment   Register Now   Isatuximab (Sarclisa™), selinexor (XPOVIO&t... Read More

Join HealthTree University's Summer School for Multiple Myeloma (and earn rewards)!

Summer School Enrollment is Open for HealthTree University! HealthTree University is a comprehensive myeloma curriculum created by our team at the Myeloma Cr... Read More

A Scoring Method to Predict the Risk of Early Infection in Multiple Myeloma patients

LIFE WITH MYELOMA - July 09, 2020

It is a lucky day when stumbling on a myeloma related article that does not take us into the world of molecular biology or investigational drugs. The Journal of... Read More

High Risk Myeloma and the Benefit of Tandem Transplants with Long-Term Revlimid Maintenance

LIFE WITH MYELOMA - July 09, 2020

This is an interesting article to write as I definitely qualify as being someone who lives with ‘high risk’ myeloma (mine is primary Plasma Cell Leu... Read More

HealthTree Research: The Intersection of Psoriasis and Multiple Myeloma

LIFE WITH MYELOMA - July 08, 2020

We are proud to share our first published study from the HealthTree platform! Thank you to all involved patients!  Psoriasis and multiple myeloma a... Read More

A Coaches Perspective: Living Well With Myeloma During a Pandemic

LIFE WITH MYELOMA - July 08, 2020

How I deal with myeloma amidst a pandemic. The first thing is, I trust in the Lord. The next thing is, I follow the COVID-19 rules. The third thing is, I kee... Read More

Cellectis UCART Multiple Myeloma Clinical Trial Placed on Hold

MYELOMA NEWS - July 08, 2020

A Phase I CAR T clinical trial (MELANI-01) by Cellectis, a French pharmaceutical company, was placed on hold by the FDA following a myeloma patient... Read More

CelMoDs: Not Just Another Immmuno-modulatory Drug

MYELOMA NEWS - July 02, 2020

“Not just another immune-modulary drug” These are the words that Dana Farber’s Dr. Paul Richardson uses to introduce us to a new class of d... Read More

Full Show: Using the Newly Approved Isatuximab in the Myeloma Clinic with Tom Martin, MD, USCF

MC RADIO - July 01, 2020

Thomas Martin, MD University of California at San Francisco Interview Date: June 5, 2020 Thanks to our episode sponsor Summary New treatment opti... Read More

Another Bi-Specific Antibody for Multiple Myeloma Treatment

MYELOMA NEWS - July 01, 2020

It seems that hardly a week goes by without news of progress in the fight against multiple myeloma. This time it comes (again) from Johnson & Johnson, the m... Read More

A Melflufen Update in Multiple Myeloma

MYELOMA NEWS - July 01, 2020

Myeloma Crowd published a post three months ago about the work of the Swedish company Oncopeptides in treating triple refractory multiple myeloma (patients... Read More

Identify Financial Resources That Will Work For You

MYELOMA COACH - July 01, 2020

How to Make Sure All of Your Financial Resources are Working For You I have been a financial advisor for more than 20 years, and more recently a Myeloma Fina... Read More

Find Myeloma Help

Myeloma Financial Resource


Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.

Myeloma Specialist


Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.

Myeloma Clinical Trials


Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.

Myeloma Coach


We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.

Thanks to our site sponsors: